🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07045688
Recruiting Not applicable

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

NCT07045688 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-05-13
Last updated
2025-07-01

Condition(s) studied

H. Pylori Infection

Investigational drug(s) / intervention(s)

Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infectionEfficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infectionEfficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection

Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection: we assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient.

Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection: we assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection: we assess the efficacy of PPI based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

Study summary

This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age: \>18 years old. * H. pylori infection: Confirmed by histopathology or non-invasive tests (e.g., stool antigen test). Exclusion Criteria: * Prior H. pylori treatment: Previous treatment for H. pylori infection. * Allergies: Known allergies to study medications or components. * Patients cannot finish treatment course. * Patient missed follow up. * Patients refusing or neglecting test of cure for H. pylori.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sohag University Hospital Sohag Egypt Recruiting

More Sohag University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07045688 on ClinicalTrials.gov ↗ ← All trials in Egypt